Belvedere Trading’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,300
Closed -$16.8K 992
2022
Q4
$16.8K Buy
+1,300
New +$24K ﹤0.01% 847
2022
Q3
Sell
-14,120
Closed -$494K 290
2022
Q2
$494K Sell
14,120
-3,130
-18% -$254K 0.02% 86
2022
Q1
$2.03M Buy
+17,250
New +$1.03M 0.05% 29

Other funds holding CELU

Belvedere Trading's CELU Position: Q2 2021 in Review

Belvedere Trading sold out of Celularity (CELU) in Q2 2021, closing a stake of 13,131 shares — an estimated $1.32M sold.

Belvedere Trading first reported a position in CELU in Q1 2021 and held it in 1 quarter. The position peaked at $1.32M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • Belvedere Trading reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • Belvedere Trading sold 13,131 Celularity shares in Q2 2021, an estimated $1.32M.
  • Belvedere Trading first reported a position in Celularity in Q1 2021 and held it in 1 quarter.
  • Belvedere Trading's Celularity position peaked at $1.32M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Belvedere Trading's 13F filing for Q2 2021, filed 23 Jul 2021.